Search
for
Sort by
Research 451–480 of 1000+
- Reply to early onset effluvium secondary to COVID-19 and body-hair effluvium
- The changing landscape of managing hair loss: a 30‐year perspective
- Alopecia areata
- In reply
- Prenatal diagnosis of a foetus with partial monosomy 4p and partial trisomy 13q
- Hair today, gone tomorrow
- Tombo em João Pessoa dá força a Memorial da Arquitetura Paraibana
- 63-Year-Old Female with Diffuse Thinning of the Hair
- JAK-STAT1 as therapeutic target for EGFR deficiency-associated inflammation and scarring alopecia
- Upadacitinib for management of recalcitrant alopecia areata: A retrospective case series
- Skin Biology and Ageing
- PKC downregulation upon rapamycin treatment attenuates mitochondrial disease
- Treatment of Crohn's Disease and Concomitant Alopecia Areata With Tofacitinib
- Clinical Outcomes for Uptitration of Baricitinib Therapy in Patients With Severe Alopecia Areata
- Tofacitinib for the treatment of severe alopecia areata and variants: A retrospective cohort study of 90 patients
- Autophagy Stimulation Improves Erythroid Proliferative Capacity in Models of SF3B1 Mutant MDS
- Les Rencontres d’Experts du Psoriasis : des recommandations pour la pratique quotidienne
- Successful treatment of concomitant alopecia universalis and Crohn’s disease with upadacitinib: A case report
- 59 Scarring alopecia is driven by the collapse of EGFR-protected JAK-STAT1-sensitive stem cell immune privilege
- An Overview about Alopecia Areata Etiopathogenesis, Diagnosis, and Management: Review Article
- New Treatment Strategies in Management of Alopecia Areata: Review Article
- Activity of Sorafenib against Desmoid Tumor/Deep Fibromatosis
- The PDGF/PDGFR pathway as a drug target
- Anti-EGFR mechanism of action: antitumor effect and underlying cause of adverse events.
- Ritlecitinib: First Approval
- Immune deficiency–related enteropathy-lymphocytopenia-alopecia syndrome results from tetratricopeptide repeat domain 7A deficiency
- A Case of Cicatricial Alopecia Associated with Erlotinib
- Phase I safety and pharmacokinetic study of SU-014813 in combination with docetaxel in patients with advanced solid tumours
- The role of oclacitinib in the management of ischaemic dermatopathy in four dogs
- Treatments options for alopecia